NUMBERS 60,290

In 2015, there will be an estimated 60,290 new cases of breast carcinoma in situ diagnosed, 83% of which will be ductal carcinoma in situ (DCIS) and 12% lobular carcinoma in situ (LCIS). This year's special section reviews breast carcinoma in situ, including incidence rates and trends, risk factors, prognostic characteristics, and treatment patterns. It is intended to inform anyone interested in learning more about breast carcinoma in situ, including policy makers, researchers, clinicians, cancer control advocates, patients, and caregivers.

Source: www.cancer.org